Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Erenumab +1 More for Migraine
Recruiting2 awardsPhase 4
Meridian, Idaho
This trial is testing a new drug to see if it can help reduce the duration of headaches that are of at least moderate pain intensity.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.